Research

The director of the Rush Alzheimer’s Disease Center envisions a solution to the disease

Rush is helping lead a new health research accelerator that has launched in the Chicago area with nearly $35 million in funding from the NIH.

Rush Alzheimer's Disease Center Director David Bennett, MD, on the search for treatment options for Alzheimer's and dementia.

A diet created by researchers at Rush may help substantially slow cognitive decline in stroke survivors

High-intensity exercise three times a week decreases worsening of the disease’s symptoms

Can the MIND Diet reduce the risk of cognitive decline and Alzheimer's disease?

Rush researchers have discovered two genes that are associated with aging individuals having better memory and brain function

Tau pathology is one of the defining features of Alzheimer disease

This finding could help researchers to understand the cause of memory loss

A study in the New England Journal of Medicine shows that suPAR, a circulating protein measured by a simple blood test, can reliably predict a person’s chances of developing chronic kidney disease as much as five years before this common killer starts causing damage.